Chris Buyse

Chris Buyse

Director/Board Member chez INVENTIVA

Fortune : - $ au 31/03/2024

59 ans
Health Technology
Finance
Communications

Profil

Chris Buyse is currently the Director at Intrexon ActoBiotics NV, Bio-Incubator Leuven, Fondation Francqui, Life Sciences Research Partners VZW, Pinnacle Investments NV, Creabuild NV, Sofia BV, Pienter-Jan BV, Inventiva SA, ImmunoPrecise Antibodies Ltd., CoBioRes NV, EyeD Pharma SA, Hyloris Pharmaceuticals SA, Cellaïon SA, Louis Jeantet Foundation, and the Managing Partner at Fund+.
Previously, Mr. Buyse served as the Chairman at Amakem NV, Director at Orgenesis, Inc., Director, Chief Executive & Financial Officer at Keyware Technologies NV, Director-Finance at MCI BeLux, Director at Ogeda SA, CFO, Executive Director & Head-Investor Relations at Oxurion NV, Non-Executive Director at Celyad Oncology SA, Finance Director at WorldCom, Inc., Director at PROMETHERA Biosciences SA, Director at Immo David NV, Independent Non-Executive Director at Bone Therapeutics SA, Director at TheraSolve NV, Director at Q-Biologicals NV, Director at iTeos Therapeutics SA, Director at Catalent Gosselies NV, Non-Executive Director at Bioxodes SA, Director at Patcobel NV, Group Controller at Unilever NV, Group Controller at smartphoto group NV, Chief Financial Officer at CropDesign NV, and Controller at Suez Lyonnaise des Eaux Finance SA. Mr. Buyse holds an MBA from Vlerick Leuven Gent Management School and a graduate degree from the University of Antwerp.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/03/2024 0 ( -.--% ) - $ 31/03/2024
19/01/2024 0 ( -.--% ) - $ 31/03/2024

Postes actifs de Chris Buyse

SociétésPosteDébut
INVENTIVA Director/Board Member 14/02/2017
HYLORIS PHARMACEUTICALS SA Director/Board Member -
IMMUNOPRECISE ANTIBODIES LTD. Director/Board Member 05/09/2023
Director/Board Member -
Director/Board Member -
Director/Board Member -
Private Equity Investor 07/05/2015
Fondation Francqui Director/Board Member -
CoBioRes NV Director/Board Member 01/01/2014
░░░░ ░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
Tous les postes actifs de Chris Buyse

Anciens postes connus de Chris Buyse

SociétésPosteFin
░░░░░░░ ░░░░░░░░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Chris Buyse

Formation de Chris Buyse

Vlerick Leuven Gent Management School Masters Business Admin
University of Antwerp Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Chris Buyse

Relations

100 +

Relations au 1er degré

39

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées8
ORGENESIS INC.

Health Technology

SMARTPHOTO GROUP NV

Retail Trade

KEYWARE TECHNOLOGIES NV

Technology Services

OXURION NV

Health Technology

CELYAD ONCOLOGY SA

Health Technology

INVENTIVA

Health Technology

IMMUNOPRECISE ANTIBODIES LTD.

Health Technology

HYLORIS PHARMACEUTICALS SA

Health Technology

Entreprise privées29

Distribution Services

Communications

Commercial Services

Health Technology

Finance

Health Technology

WorldCom, Inc. /Old/

Communications

Finance

Health Technology

Fondation Francqui

Health Services

Miscellaneous

Pinnacle Investments NV

Finance

Commercial Services

Health Technology

Communications

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Finance

CoBioRes NV

Health Technology

Finance

Health Technology

Louis Jeantet Foundation

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Chris Buyse